TABLE 2.
Endo group | Non‐Endo group | p‐value | ||
---|---|---|---|---|
(n = 18) | (n = 18) | |||
Age (years, mean ± SD) | 37.9 ± 6.4 | 35.2 ± 8.6 | 0.29 | |
Range in age (years) | 27–49 | 20–49 | ||
Parity (n, mean ± SD) | 0.6 ± 0.8 | 1.1 ± 1.3 | 0.29 | |
Gravidity (n, mean ± SD) | 0.4 ± 0.8 | 0.8 ± 1.0 | 0.18 | |
Body mass index | 22.4 ± 2.9 | 23.0 ± 4.9 | 0.99 | |
Type of tumor | Endometriosis | Mature cystic teratoma | n = 14 | |
Mucinous cyst adenoma | n = 2 | |||
Paraovarian cyst | n = 1 | |||
Struma ovarii | n = 1 | |||
Site of lesion (n) | ||||
Bilateral | 10 | 1 | ||
Unilateral | 8 | 17 | ||
Maximum diameter of tumor (cm, mean ± SD) | 6.2 ± 2.8 | 7.7 ± 3.0 | 0.17 | |
Revised ASRM staging | ||||
Stage Ⅲ | 5 | |||
Stage IV | 13 | |||
Hormone use within 3 months of surgery (n) | 4 | 1 | 0.34 |